:quality(85)//cloudfront-us-east-1.images.arcpublishing.com/infobae/BZAXKQSPLO7QEAQ75EBS5HLOSY.jpg "Bayer plans to assist CureVac in COVID vaccine production 1")
Read more from Author Ben Oakley here: https://globelivemedia.com/author/ben-oakley/
BERLIN, Jan 17 (Reuters) – German pharmaceutical giant Bayer is studying the possibility of helping CureVac produce its COVID-19 vaccine, CEO Werner Baumann told the Welt am Sonntag newspaper on Sunday. .
“We are prepared to do everything possible in that regard,” he said. “This is not primarily about financial considerations, but about making the vaccine available as soon as possible.”
Bayer agreed this month to help fellow German CureVac with the development of its COVID-19 vaccine, which is in the final phase of clinical trials and has yet to be approved.
“With our production network in Germany and the US and the corresponding delivery time, in principle we would be able to produce the vaccine in larger quantities,” Baumann added.
(Information by Caroline Copley; edited by David Goodman; translated by Jorge Martínez)